ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds

June 18, 1976

Kimes: Centers Need New $$ Sources; Fox Chase, U.Pa Go Seperate Ways

October 12, 1990

NCI Directory Delayed

January 27, 1984

Computer Learning May Help Women In Treatment Decision

October 30, 2009

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002

President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget

February 5, 1999